{"id":342589,"date":"2026-11-09T11:33:04","date_gmt":"2026-11-09T06:03:04","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=342589"},"modified":"2026-11-09T11:33:04","modified_gmt":"2026-11-09T06:03:04","slug":"divis-laboratories-share-price-record-high-9-november-2026-q2-fy27-profit-up-64-percent-buy-sell-or-hold","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/divis-laboratories-share-price-record-high-9-november-2026-q2-fy27-profit-up-64-percent-buy-sell-or-hold\/","title":{"rendered":"Divi’s Laboratories Share Price Hits a Record High, Up 84% This Year: Buy, Sell or Hold After the Q2 FY27 Profit Jump?"},"content":{"rendered":"

Divi’s Labs hit a record high on 9 Nov 2026 (Mint). Q2 FY27 PAT Rs 1,127 crore, up 63.6%; EBITDA margin 42.6%. Business Standard: market cap above Rs 3 trillion.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Divi’s Laboratories share price hit a record high on 9 November 2026, up about 84% this year according to Mint, after Q2 FY27 profit rose 64% to Rs 1,127 crore and EBITDA margin widened to 42.6%. Business Standard reported a 15% rally in two days and a market cap above Rs 3 trillion, so valuation is now the central question.<\/p>\n<\/p><\/div>\n

The Divi’s Laboratories share price<\/strong> hit a record high<\/strong> on 9 November 2026, and Mint asks whether to buy, sell or hold. Univest does not recommend securities, so this article sets out the Q2 FY27 numbers, what drove them, how the valuation and analyst opinions look, and what to check before deciding. Figures are attributed and time-stamped, and I have no live quote.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n